- 201-500 Employees
- Based in Vancouver, British Columbia
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, zanidatamab (ZW25), is a novel Azymetric…More
Most Recent Responsibility Report
2022 ESG Report
Report Locked. Zymeworks Inc. has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived Zymeworks Inc. Sustainability Report, Zymeworks Inc. Corporate Social Responsibility Report, Zymeworks Inc. CSR Report, Zymeworks Inc. Corporate Responsibility, Zymeworks Inc. CR Report, Zymeworks Inc. Citizenship Report, Zymeworks Inc. ESG Report, and Zymeworks Inc. Environmental Report online.